Igor-Magnum Experiment 99L

The chart shows the growth of an initial investment of $10,000 in Igor-Magnum Experiment 99L, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Oct 1, 2020, Igor-Magnum Experiment 99L's average daily return is +0.10%, while the average monthly return is +2.19%. At this rate, your investment would double in approximately 2.7 years.

Historically, 73% of months were positive and 27% were negative. The best month was Nov 2020 with a return of +23.9%, while the worst month was Jun 2022 at -8.1%. The longest winning streak lasted 13 consecutive months, and the longest losing streak was 3 months.

On a daily basis, Igor-Magnum Experiment 99L closed higher 56% of trading days. The best single day was Apr 9, 2025 with a return of +7.6%, while the worst single day was Apr 4, 2025 at -7.3%.

Igor-Magnum Experiment 99L has an annualized alpha of 17.02%, beta of 0.78, and R² of 0.68 versus S&P 500 Index. Calculated based on daily prices since October 01, 2020.

• This portfolio captured 116.07% of S&P 500 Index gains but only 49.36% of its losses — a favorable profile for investors.
• This portfolio generated an annualized alpha of 17.02% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.

Igor-Magnum Experiment 99L has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Igor-Magnum Experiment 99L ranks 60 for risk / return — on par with similar portfolios. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Igor-Magnum Experiment 99L Sharpe ratios as of Apr 3, 2026 (values are recalculated daily):

• 1-Year: 1.31
• 5-Year: 1.55
• All Time: 1.79

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.97 to 1.66, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of Igor-Magnum Experiment 99L compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Igor-Magnum Experiment 99L provided a 1.54% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Igor-Magnum Experiment 99L. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Igor-Magnum Experiment 99L was 20.55%, occurring on Sep 30, 2022. Recovery took 175 trading sessions.

The current Igor-Magnum Experiment 99L drawdown is 4.48%.

The chart below shows the rolling one-month volatility.